Community-driven development of a modified progression-free survival ratio for precision oncology-Reference-Cited by-同舟云学术

Community-driven development of a modified progression-free survival ratio for precision oncology

Published:2019 Issue:6 Volume:4 Page:e000583
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Mock Andreas^ORCID,Heilig Christoph E,Kreutzfeldt Simon,Huebschmann Daniel,Heining Christoph,Schröck Evelin,Brors Benedikt,Stenzinger Albrecht,Jäger Dirk,Schlenk Richard,Glimm Hanno,Fröhling Stefan,Horak Peter^ORCID,Apostolidis Leonidas,Augustin Marinela,Aust Daniela,Bhatti Irfan Ahmed,Bloehdorn Johannes,Brendel Cornelia,Britschgi Christian,Braess Jan,Burdach Stefan,Busch Elena,Casuscelli Jozefina,Desuki Alexander,Deutsch Thomas,Dietrich Mareike,Ehmer Ursula,Ettrich Thomas J,Falkenhorst Johanna,Fehm Tanja,Flörcken Anne,Forschner Andrea,Fuxius Stefan,Gonzales-Carmona Maria,Griesinger Frank,Grill Sabine,Gröschel Stefan,Haag Georg Martin,Haag Ulrich,Halama Niels,Hebart Holger,Heidger Nina,Hermes Barbara,Hess Georg,Hettmer Simone,Hoechstetter Manuela,Hoffmann Martin,Hüttner Felix J,Illert Anna L,Jenzer Maximilian,Kasper Bernd,Kasper-Virchow Stefan,Kindler Thomas,Koscielniak Ewa,Krönke Jan,Kühn Michael,Kunzmann Volker,Lang Alois,Leichsenring Jonas,Livingstone Elisabeth,Liotta Lucia,Luley Kim,Mack Elisabeth,Martens Uwe M,Metzeler Klaus,Middeke Jan Moritz,Möhrmann Lino,Jayarama-Naidu Roopa,Pape Ulrich-Frank,Perkhofer Lukas,Pfeufer Arne,Pixberg Constantin,Quante Michael,Rendenbach Bernhard,Rieke Damian,Rothermundt Christian,Sagerer Andre Norbert,Salzmann Martin,Saur Dieter,Schilling Bastian,Schleicher Jan,Schlenska-Lange Anke,Schmidt Thomas,Schmitz Sophia,Schölch Sebastian,Shah Rajiv,Shoumariyeh Khalid,Siebenhüner Alexander,Singh Martin,Siveke Jens,Springfeld Christoph,Starke Helen,Strobel Sophia,Teleanu Veronica,Thon Niklas,Wagner Sebastian,Walle Thomas,Westphalen Benedikt,Whitlock Bettina,Winkler Eva,Wirsik Naita Maren,Woydack Lena,Bois Angelika Zabel-du,Zschäbitz Stefanie

Funder

Faculty of Medicine, Heidelberg University

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. Challenging standard-of-care paradigms in the precision oncology era;Subbiah;Trends Cancer,2018

2. Comparative assessment of clinical benefit using the ESMO-magnitude of clinical benefit scale version 1.1 and the ASCO value framework net health benefit score;Cherny;J Clin Oncol,2019

3. Overall survival: still the gold standard;Driscoll;Cancer J,2009

4. The evidence framework for precision cancer medicine;Moscow;Nat Rev Clin Oncol,2018

5. Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers;Von Hoff;J Clin Oncol,2010

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. App-based assessment of patient-reported outcomes in the Molecular Tumor Board in the Center for Personalized Medicine—(TRACE);Neuro-Oncology Practice;2024-01-20

2. Molekulare Tumorboards;Forum;2024-01-12

3. Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment;Scientific Reports;2023-09-18

4. A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich;Targeted Oncology;2023-08-18

5. Overall survival benefit of patients with biliary tract cancer receiving molecular profiling: a real-world multicenter retrospective cohort analysis;2023-08-01